- Home
- LITB vs OTLK Comparison
LITB vs OTLK Comparison
Compare LITB & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- OTLK
- Stock Information
- Founded
- LITB 2007
- OTLK 2010
- Country
- LITB Singapore
- OTLK United States
- Employees
- LITB N/A
- OTLK N/A
- Industry
- LITB Catalog/Specialty Distribution
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LITB Consumer Discretionary
- OTLK Health Care
- Exchange
- LITB Nasdaq
- OTLK Nasdaq
- Market Cap
- LITB 36.4M
- OTLK 42.8M
- IPO Year
- LITB N/A
- OTLK 2016
- Fundamental
- Price
- LITB $3.03
- OTLK $1.25
- Analyst Decision
- LITB
- OTLK Buy
- Analyst Count
- LITB 0
- OTLK 5
- Target Price
- LITB N/A
- OTLK $5.25
- AVG Volume (30 Days)
- LITB 34.1K
- OTLK 1.3M
- Earning Date
- LITB 12-09-2025
- OTLK 08-14-2025
- Dividend Yield
- LITB N/A
- OTLK N/A
- EPS Growth
- LITB N/A
- OTLK N/A
- EPS
- LITB 0.12
- OTLK N/A
- Revenue
- LITB $220,656,000.00
- OTLK $1,505,322.00
- Revenue This Year
- LITB N/A
- OTLK N/A
- Revenue Next Year
- LITB N/A
- OTLK $342.80
- P/E Ratio
- LITB $25.19
- OTLK N/A
- Revenue Growth
- LITB N/A
- OTLK N/A
- 52 Week Low
- LITB $0.91
- OTLK $0.79
- 52 Week High
- LITB $4.17
- OTLK $6.98
- Technical
- Relative Strength Index (RSI)
- LITB 55.56
- OTLK 47.93
- Support Level
- LITB $2.54
- OTLK $1.28
- Resistance Level
- LITB $4.17
- OTLK $1.31
- Average True Range (ATR)
- LITB 0.47
- OTLK 0.09
- MACD
- LITB 0.01
- OTLK -0.01
- Stochastic Oscillator
- LITB 40.30
- OTLK 16.36
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.